Immix Biopharma, Inc.

IMMX

Immix Biopharma, Inc.

IMMX

Insider Sentiment (TTM):

Last Purchase:2025-12-10Last Sale:-Shares Purchased (TTM):6,616Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:26,583,656Shares Outstanding:55,369,123Institutional Ownership Pct.:48.01%

Earnings Market Reaction:

Filing Date:2026-08-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	225	79	94	16	12	16	18	20	24	29	18	20
Income Tax Receivable	-	0	-	-	-	-	2	2	2	2	1	1
Assets Current
Assets Current	234	92	101	17	12	17	20	23	27	33	20	22
Short Term Investments	7	11	6	-	-	-	-	-	-	-	-	-
Prepaid Expense And Other Assets Current	2	2	1	1	1	1	1	1	1	2	1	2
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	-	0
Deferred Costs	-	0	0	0	0	-	-	-	-	-	0	-
Operating Lease Right Of Use Asset	1	1	1	1	1	1	1	1	1	1	-	-
Property Plant And Equipment Net	2	2	3	2	2	2	2	1	0	0	0	0
Assets	239	96	105	20	16	20	23	25	29	34	20	22
Liabilities And Stockhold…
Accounts Payable And Accrued Liabilities Current	9	10	10	11	10	9	9	7	4	6	4	3
Liabilities Current
Liabilities Current	9	11	10	11	10	9	9	7	4	6	4	3
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	-	-
Operating Lease Liability Noncurrent	1	1	1	1	1	1	1	1	1	1	-	-
Liabilities	10	11	11	12	11	10	10	8	5	7	4	3
Stockholders Equity Inclu…
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	355	199	198	102	91	89	88	88	87	87	70	68
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	-0	0	0	0	0	0
Stockholders Equity	229	84	94	8	5	10	13	18	24	28	16	20
Retained Earnings Accumulated Deficit	-126	-115	-104	-94	-86	-80	-75	-70	-63	-59	-53	-48
Treasury Stock Value	-	-	-	-	-	-	-0	-0	-0	-0	-0	-0
Treasury Stock Common Value	-0	-0	-0	-0	-0	-0	-0	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-0	-0	-0
Liabilities And Stockholders Equity	239	96	105	20	16	20	23	25	29	34	20	22
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Common Stock Shares Issued	72	53	53	33	28	28	28	28	28	26	20	20
Shares Outstanding	72	53	53	33	28	28	28	27	27	26	20	20
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-5.66%	4.61%	-10.69%	-	-	-	-	-	-	-	-	-
2025	9.09%	1.17%	26.34%	-7.11%	-12.97%	51.05%	34.92%	79.05%	70.79%	16.16%	11.56%	-5.16%
2024	-3.21%	-9.17%	2.75%	6.49%	-11.89%	-14.05%	47.67%	36.63%	12.79%	-11.35%	11.35%	27.03%
2023	-	-	-	25.82%	87.91%	86.26%	12.94%	46.82%	-11.29%	-	-	-
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	25.13	8.76	10.01	1.53	1.23	1.80	2.33	3.47	7.00	5.82	5.32	7.90
Quick Ratio	24.95	8.59	9.93	1.47	1.16	1.71	2.26	3.30	6.65	5.54	5.02	7.16
Working Capital	224.49M	81.74M	91.13M	5.73M	2.32M	7.47M	11.51M	16.19M	23.43M	27.26M	16.07M	19.51M
Leverage & Debt
Debt to Equity	0.04	0.14	0.12	1.43	2.36	1.07	0.73	0.43	0.21	0.24	0.23	0.14
Interest Coverage TTM	-	-	-	-	-	-	-	-	-	-	-	-29,295.45
Debt Ratio	0.04	0.12	0.11	0.59	0.70	0.52	0.42	0.30	0.17	0.20	0.19	0.13
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.63	-0.63	-0.89	-0.74	-0.77	-0.70	-0.76	-0.75	-0.66	-0.78	-0.89	-0.76
Free Cash Flow Per Share TTM	-0.49	-0.59	-0.75	-0.43	-0.39	-0.45	-0.56	-0.56	-0.53	-0.57	-0.66	-0.68
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	73.30%	68.05%	36.21%	7.03%	20.85%	14.05%	40.11%	54.73%	66.80%	94.33%	87.44%	220.03%
EPS Growth (1Y)	-18.52%	-9.85%	16.87%	-1.36%	16.02%	-10.00%	-14.10%	-2.31%	-12.86%	15.23%	50.11%	139.86%
Valuation Metrics
P/E TTM	-16.47	-14.41	-5.86	-2.84	-2.69	-2.40	-2.88	-2.00	-2.99	-3.94	-7.78	-4.48
P/B TTM	2.87	5.98	1.84	8.07	13.34	5.20	4.70	2.50	2.39	2.60	7.41	3.23
Market Cap	657.48M	504.41M	172.41M	66.73M	62.07M	49.90M	62.23M	43.84M	56.99M	71.96M	120.00M	63.54M
Enterprise Value	431.99M	425.16M	78.48M	50.78M	50.43M	33.98M	44.55M	24.15M	33.02M	42.64M	102.49M	43.96M
Calculated Values
Free Cash Flow TTM	-31.01M	-32.77M	-24.66M	-13.70M	-11.73M	-13.40M	-15.77M	-16.48M	-15.30M	-13.46M	-11.42M	-12.64M
Net Debt	-225.49M	-79.25M	-93.93M	-15.95M	-11.64M	-15.92M	-17.68M	-19.69M	-23.98M	-29.32M	-17.51M	-19.58M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-10Purchase

Owner: Morris, Gabriel S

Title: CFO

Shares: 770

Price/Share: $6.58

Value: $5,066.60

Shares Owned: 291,429

Relationship: Director,Officer

Ownership: Direct

2025-12-10Purchase

Owner: Rachman, Ilya M

Title: CEO and Chairman

Shares: 746

Price/Share: $6.67

Value: $4,975.82

Shares Owned: 1,141,683

Relationship: Director,Officer

Ownership: Direct

2025-09-17Purchase

Owner: Rachman, Ilya M

Title: CEO and Chairman

Shares: 2,500

Price/Share: $2.02

Value: $5,050.00

Shares Owned: 1,140,937

Relationship: Director,Officer

Ownership: Direct

2025-09-16Purchase

Owner: Morris, Gabriel S

Title: CFO

Shares: 2,600

Price/Share: $1.97

Value: $5,122.00

Shares Owned: 290,659

Relationship: Director,Officer

Ownership: Direct

2025-06-18Purchase

Owner: Rachman, Ilya M

Title: CEO and Chairman

Shares: 2,178

Price/Share: $2.30

Value: $5,009.40

Shares Owned: 1,138,437

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-10	Morris, Gabriel S	Director,Officer	CFO	Direct	Purchase	770	6.58	$5,066.60	291,429	4
2025-12-10	Rachman, Ilya M	Director,Officer	CEO and Chairman	Direct	Purchase	746	6.67	$4,975.82	1,141,683	4
2025-09-17	Rachman, Ilya M	Director,Officer	CEO and Chairman	Direct	Purchase	2,500	2.02	$5,050.00	1,140,937	4
2025-09-16	Morris, Gabriel S	Director,Officer	CFO	Direct	Purchase	2,600	1.97	$5,122.00	290,659	4
2025-06-18	Rachman, Ilya M	Director,Officer	CEO and Chairman	Direct	Purchase	2,178	2.30	$5,009.40	1,138,437	4
2025-06-18	Morris, Gabriel S	Director,Officer	CFO	Direct	Purchase	2,225	2.28	$5,073.00	288,059	4
2024-12-23	Hsu, Jason	Director	-	Direct	Purchase	40,000	2.19	$87,600.00	893,000	4
2024-08-22	Hsu, Jason	Director	-	Direct	Purchase	8,100	2.25	$18,225.00	845,300	4
2024-08-16	Ng, Carey	Director	-	Direct	Purchase	10,000	1.86	$18,600.00	20,000	4
2024-07-24	Hsu, Jason	Director	-	Direct	Purchase	6,000	2.15	$12,900.00	822,200	4
2024-06-07	Rachman, Ilya M	Director,Officer	CEO and Chairman	Direct	Purchase	2,600	2.13	$5,538.00	1,136,259	4
2024-06-07	Morris, Gabriel S	Director,Officer	CFO	Direct	Purchase	2,500	2.12	$5,300.00	285,834	4
2024-06-04	Morris, Gabriel S	Director,Officer	CFO	Direct	Purchase	3,300	1.81	$5,973.00	283,334	4
2024-06-04	Rachman, Ilya M	Director,Officer	CEO and Chairman	Direct	Purchase	3,300	1.81	$5,973.00	1,133,659	4
2024-05-14	Morris, Gabriel S	Director,Officer	CFO	Direct	Purchase	4,500	2.23	$10,035.00	85,816	4
2024-05-14	Rachman, Ilya M	Director,Officer	CEO and Chairman	Direct	Purchase	4,300	2.25	$9,675.00	912,000	4
2023-12-11	Hsu, Jason	Director	-	Direct	Purchase	31,000	4.67	$144,770.00	813,000	4
2023-09-15	Hsu, Jason	Director	-	Direct	Purchase	7,000	2.49	$17,430.00	757,000	4
2023-09-14	Ng, Carey	Director	-	Direct	Purchase	10,000	2.58	$25,800.00	10,000	4
2023-09-12	Adams, Helen C.	Director	-	Direct	Purchase	13,000	2.96	$38,480.00	13,000	4
2023-09-08	Hsu, Jason	Director	-	Direct	Purchase	10,000	2.53	$25,300.00	685,000	4
2023-09-07	Buchan, Melissa Jane	Director	-	Direct	Purchase	20,000	2.46	$49,200.00	20,000	4
2023-09-06	Marquet, Magda	Director	-	Indirect	Purchase	9,000	2.47	$22,230.00	20,000	4
2023-09-05	Marquet, Magda	Director	-	Indirect	Purchase	10,000	2.47	$24,700.00	11,000	4
2023-08-31	Marquet, Magda	Director	-	Indirect	Purchase	1,000	2.01	$2,010.00	1,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

48.01%

Inst. Shares: 26,583,656

Shares Outstanding: 55,369,123

2025-12-31

73.72%

Inst. Shares: 24,301,259

Shares Outstanding: 32,965,706

2025-09-30

8.64%

Inst. Shares: 2,759,904

Shares Outstanding: 31,926,651

2025-06-30

7.43%

Inst. Shares: 2,228,376

Shares Outstanding: 29,983,764

2025-03-31

9.73%

Inst. Shares: 2,890,180

Shares Outstanding: 29,701,080

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	26,583,656	55,369,123	48.01%
2025-12-31	24,301,259	32,965,706	73.72%
2025-09-30	2,759,904	31,926,651	8.64%
2025-06-30	2,228,376	29,983,764	7.43%
2025-03-31	2,890,180	29,701,080	9.73%
2024-12-31	2,816,394	28,285,637	9.96%
2024-09-30	4,068,613	29,424,444	13.83%
2024-06-30	4,359,004	28,785,223	15.14%
2024-03-31	4,772,727	23,438,143	20.36%
2023-12-31	721,128	17,341,146	4.16%
2023-09-30	376,225	18,578,414	2.03%
2023-06-30	622,760	15,038,989	4.14%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Immix Biopharma, Inc. (IMMX) — SEC Financial Statements & Analysis

Immix Biopharma, Inc. (IMMX) is a pharmaceutical preparations company, incorporated in DE. Immix Biopharma, Inc. trades on Nasdaq as: IMMX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Immix Biopharma, Inc. reported a Debt-to-Equity ratio of 0.04x, a Price-to-Book (P/B) ratio of 2.87x (TTM), at a market cap of $657.48M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.04x
P/B TTM: 2.87x
Market Cap: $657.48M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Immix Biopharma, Inc. in?

Immix Biopharma, Inc. (IMMX) operates in the Pharmaceutical Preparations industry.

What is IMMX's market cap?

Immix Biopharma, Inc. (IMMX) has a market capitalization of $657.48M as of 2026-06-30.

What exchange does IMMX trade on?

Immix Biopharma, Inc. (IMMX) trades on the Nasdaq.

Where is Immix Biopharma, Inc. incorporated?

Immix Biopharma, Inc. is incorporated in DE.